Controversies in blood pressure goal guidelines and masked hypertension

Research output: Contribution to journalArticle

In uncomplicated hypertension, <140/90 mmHg is the treatment goal for individuals aged 18-79 and between 140 mmHg and 150 mmHg in those 80 years of age. Inhibitors of the renin-angiotensin-aldosterone system, as well as calcium channel blockers, are universally accepted as first-line therapy in uncomplicated hypertension, but controversy exists over the role of thiazide diuretics and beta blockers. Because at similar blood pressure (BP) levels, African Americans have more target organ damage than whites, a lower goal of <135/85 mmHg is recommended. In patients with coronary artery disease, diabetes, and chronic kidney disease, <130/80 mmHg is recommended. Masked hypertension, defined as normal clinic BP with a high average self-monitored or ambulatory BP, is prevalent in those with chronic kidney disease, diabetes, and obstructive sleep apnea. Masked hypertension is associated with worse outcome. Ambulatory BP monitoring for those at risk for masked hypertension needs to be incorporated into guidelines.

Original languageEnglish (US)
Pages (from-to)115-122
Number of pages8
JournalAnnals of the New York Academy of Sciences
Volume1254
Issue number1
DOIs
StatePublished - Jan 1 2012

PMID: 22548577

Altmetrics

Cite this

Standard

Controversies in blood pressure goal guidelines and masked hypertension. / Phillips, Robert A.

In: Annals of the New York Academy of Sciences, Vol. 1254, No. 1, 01.01.2012, p. 115-122.

Research output: Contribution to journalArticle

Harvard

Phillips, RA 2012, 'Controversies in blood pressure goal guidelines and masked hypertension' Annals of the New York Academy of Sciences, vol. 1254, no. 1, pp. 115-122. https://doi.org/10.1111/j.1749-6632.2012.06489.x

APA

Phillips, R. A. (2012). Controversies in blood pressure goal guidelines and masked hypertension. Annals of the New York Academy of Sciences, 1254(1), 115-122. https://doi.org/10.1111/j.1749-6632.2012.06489.x

Vancouver

Phillips RA. Controversies in blood pressure goal guidelines and masked hypertension. Annals of the New York Academy of Sciences. 2012 Jan 1;1254(1):115-122. https://doi.org/10.1111/j.1749-6632.2012.06489.x

Author

Phillips, Robert A. / Controversies in blood pressure goal guidelines and masked hypertension. In: Annals of the New York Academy of Sciences. 2012 ; Vol. 1254, No. 1. pp. 115-122.

BibTeX

@article{76b8a94039414052b8e9bc26dd4afad7,
title = "Controversies in blood pressure goal guidelines and masked hypertension",
abstract = "In uncomplicated hypertension, <140/90 mmHg is the treatment goal for individuals aged 18-79 and between 140 mmHg and 150 mmHg in those 80 years of age. Inhibitors of the renin-angiotensin-aldosterone system, as well as calcium channel blockers, are universally accepted as first-line therapy in uncomplicated hypertension, but controversy exists over the role of thiazide diuretics and beta blockers. Because at similar blood pressure (BP) levels, African Americans have more target organ damage than whites, a lower goal of <135/85 mmHg is recommended. In patients with coronary artery disease, diabetes, and chronic kidney disease, <130/80 mmHg is recommended. Masked hypertension, defined as normal clinic BP with a high average self-monitored or ambulatory BP, is prevalent in those with chronic kidney disease, diabetes, and obstructive sleep apnea. Masked hypertension is associated with worse outcome. Ambulatory BP monitoring for those at risk for masked hypertension needs to be incorporated into guidelines.",
keywords = "Blood pressure, Essential hypertension, Guidelines, Masked hypertension",
author = "Phillips, {Robert A.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1111/j.1749-6632.2012.06489.x",
language = "English (US)",
volume = "1254",
pages = "115--122",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley",
number = "1",

}

RIS

TY - JOUR

T1 - Controversies in blood pressure goal guidelines and masked hypertension

AU - Phillips, Robert A.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - In uncomplicated hypertension, <140/90 mmHg is the treatment goal for individuals aged 18-79 and between 140 mmHg and 150 mmHg in those 80 years of age. Inhibitors of the renin-angiotensin-aldosterone system, as well as calcium channel blockers, are universally accepted as first-line therapy in uncomplicated hypertension, but controversy exists over the role of thiazide diuretics and beta blockers. Because at similar blood pressure (BP) levels, African Americans have more target organ damage than whites, a lower goal of <135/85 mmHg is recommended. In patients with coronary artery disease, diabetes, and chronic kidney disease, <130/80 mmHg is recommended. Masked hypertension, defined as normal clinic BP with a high average self-monitored or ambulatory BP, is prevalent in those with chronic kidney disease, diabetes, and obstructive sleep apnea. Masked hypertension is associated with worse outcome. Ambulatory BP monitoring for those at risk for masked hypertension needs to be incorporated into guidelines.

AB - In uncomplicated hypertension, <140/90 mmHg is the treatment goal for individuals aged 18-79 and between 140 mmHg and 150 mmHg in those 80 years of age. Inhibitors of the renin-angiotensin-aldosterone system, as well as calcium channel blockers, are universally accepted as first-line therapy in uncomplicated hypertension, but controversy exists over the role of thiazide diuretics and beta blockers. Because at similar blood pressure (BP) levels, African Americans have more target organ damage than whites, a lower goal of <135/85 mmHg is recommended. In patients with coronary artery disease, diabetes, and chronic kidney disease, <130/80 mmHg is recommended. Masked hypertension, defined as normal clinic BP with a high average self-monitored or ambulatory BP, is prevalent in those with chronic kidney disease, diabetes, and obstructive sleep apnea. Masked hypertension is associated with worse outcome. Ambulatory BP monitoring for those at risk for masked hypertension needs to be incorporated into guidelines.

KW - Blood pressure

KW - Essential hypertension

KW - Guidelines

KW - Masked hypertension

UR - http://www.scopus.com/inward/record.url?scp=84860474803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860474803&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.2012.06489.x

DO - 10.1111/j.1749-6632.2012.06489.x

M3 - Article

VL - 1254

SP - 115

EP - 122

JO - Annals of the New York Academy of Sciences

T2 - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

IS - 1

ER -

ID: 16828297